Skip to main content

Bibiana Planas Ribas

Institutions of which they are part

Infectious Diseases
Vall Hebron Institut de Recerca

Bibiana Planas Ribas

Institutions of which they are part

Infectious Diseases
Vall Hebron Institut de Recerca

Projects

Clinical Efficacy of oral Cefixime and Fosfomycin-Trometamol in the Treatment of Acute Bacterial Prostatitis (CEFOSPROST): a pilot, comparative, randomized, open, multicenter trial.

IP: Joaquin Burgos Cibrian
Collaborators: Bibiana Planas Ribas, Marta Sanchiz Cruz, Paula Suanzes Diez
Funding agency: Instituto de Salud Carlos III
Funding: 190000
Reference: PI23/01184
Duration: 01/01/2024 - 31/12/2026

Malalties infeccioses

IP: Vicenç Falcó Ferrer
Collaborators: Jose Santos Santiago, Maria Luisa Aznar Ruiz de Alegria, Adria Curran Fàbregas, Jorge Nestor Garcia Perez, Oscar Len Abad, Mª Carmen Ferrer Barberà, Javier Gomis Rodriguez, Diana Pou Ciruelo, Begoña Treviño Maruri, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Juan Espinosa Pereiro, Bibiana Planas Ribas, Ma Dolores Rodríguez Pardo, Pau Bosch Nicolau, David Perea Pérez, Israel Molina Romero, Patricia Álvarez López, Luis Lopez Perez, Vicente Descalzo Jorro, Marta Sanchiz Cruz, Nuria Serre Delcor, Laura Escola Verge, Julia Sellares Nadal, Fernando M Salvador Velez, Isabel Ruiz Camps, Jordi Gómez i Prat, María José Buzón Gómez, Hakima Ouaarab Essadek, Paula Suanzes Diez, Jordi Navarro Mercadé, Esperanza Esteban Serna, Raisa Morales Martinez, Joaquin Burgos Cibrian, Nerea Sanchez Gaona, Joan Rey Cano, Adrián Sánchez Montalvá, Cristina Mancebo Perez, Montserrat Llinás Vidal, Ana Gallego Cortes, Maider Arando Lasagabaster, Ibai Los Arcos Bertiz, Claudia Broto Cortes, Ester Marquez Algaba, Benito Almirante Gragera, Desideria Martinez Rascón, Meritxell Genesca Ferrer, Ines Mercedes Oliveira Souto, Silvina Andrea Magnani, Yasmine Margaret Baktash
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00764
Duration: 01/01/2022 - 30/06/2025

Impact of early treatment during acute HIV infection on the metabolism of reservoir and immune effector cells: Identification of new targets to reduce persistent HIV

IP: Jordi Navarro Mercadé
Collaborators: Adria Curran Fàbregas, Jorge Nestor Garcia Perez, Vicenç Falcó Ferrer, Bibiana Planas Ribas, Vicente Descalzo Jorro, Paula Suanzes Diez, Judit Grau Exposito
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI20/00823
Duration: 01/01/2021 - 30/06/2025

Pesquisa operativa contra a desnutrição crônica infantil em Angola (Projeto CRESCER)

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Elena del Carmen Trigo Esteban, Bibiana Planas Ribas, Marta Sanchiz Cruz, Marc Molins Masdefiol, Ferran Ramirez Viaplana, Esperanza Esteban Serna, Josep Roca Grande, Aguado Lobo, Isabel, Jose Cabral Jamba, Gemma Abad Pérez
Funding agency: EUROPEAN COMMISSION
Funding: 3004510.89
Reference: CRESCER_EUROPEAID2019_
Duration: 15/02/2021 - 14/02/2025

Related news

The new protocol has the same efficacy as the standard one, but only a quarter of the duration, reducing dropout rates and side effects.

The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease

The study shows that blocking the KLRG1 receptor helps to recover the activity of the natural killer cells of the immune system and reactivate the virus reservoir to fight infection.

Related professionals

Daniel López Torres

Daniel López Torres

Read more
Mónica López Bardasco

Mónica López Bardasco

Administrative
Employment Relations Unit
Human Resources and Lega Area
Read more
Carla Carbonell Rosell

Carla Carbonell Rosell

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Lucy Dougherty de Miguel

Lucy Dougherty de Miguel

Predoctoral researcher
Pediatric Neurology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.